Emergence of resistance to tyrosine kinase inhibitors in non-small-cell lung cancer can be delayed by an upfront combination with the HSP90 inhibitor onalespibAurélie Courtin, Nicola G. Wallis|British Journal of Cancer|2016Cited by 28